HOME >> BIOLOGY >> NEWS
Role for proteomics in identifying hematologic malignancies

BOSTON Scientists have identified a set of biomarkers that could help clinicians identify a group of hematologic malignancies known as myelodysplastic syndromes (MDS), which affect approximately 300,000 individuals worldwide and often progress to acute myeloid leukemia.

Reported in the advance issue of the Proceedings of the National Academy of Sciences (which appears on-line the week of January 8) the findings point to a possible new diagnostic method for these malignancies, which occur when blood cells remain in an immature stage within the bone marrow and never sufficiently develop into the mature cells necessary for proper hematologic functioning. The study was led by researchers at Beth Israel Deaconess Medical Center (BIDMC) and Heinrich Heine University in Duesseldorf, Germany.

"Currently, a bone marrow biopsy is the only definitive means available to diagnose MDS," explains senior author Towia Libermann, PhD, Director of the Genomics Center at BIDMC and director of the Dana-Farber/Harvard Cancer Center Cancer Proteomics Core. "And since this group of malignancies primarily affects elderly patients, such a procedure is particularly arduous and sometimes impossible."

Therefore, first author Manuel Aivado, MD, PhD, a member of the Libermann laboratory and Lecturer in Medicine at Harvard Medical School (HMS), devised a clinical study to test whether serum proteomic profiling might be used to identify biomarkers for MDS.

The large-scale study of proteins -- including their expression, modification, composition, structure and function -- the field of proteomics is proving instrumental in the identification of molecular biomarkers, such as those that indicate a particular disease, according to Libermann, who is also Associate Professor of Medicine at HMS.

Aivado and Libermann used a combination of two technologies -- protein fractionation and mass spectrometry to create proteome profiles from the serum of 218 pati
'"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
11-Jan-2007


Page: 1 2

Related biology news :

1. New proteomics research promises to revolutionize biomedical discovery
2. Lab-on-a-chip device from Berkeley Lab to speed proteomics research
3. An infectious agent of deception, exposed through proteomics
4. NIST and NCI to collaborate on proteomics assessment
5. Advanced genomics and proteomics improve the diagnosis and treatment of a deadly lung disease
6. New Columbia University center aims to advance next generation of genomics, proteomics research
7. Premature births from inflammation and infection rapidly detected by proteomics technology
8. Searle grant funds proteomics initiative
9. Researchers discover method for identifying how cancer evades the immune system
10. Study identifying alteration in gene associated with uterine cancer
11. Stem cells provide new tool for studying disease and identifying ALS drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/23/2019)... ... July 22, 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human ... for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. The ... of osteoarthritis in the knee. , This is the first of several ...
(Date:7/21/2019)... ... July 20, 2019 , ... ... Technologies ( http://www.fluidimaging.com ) announced today the release of the biggest software ... imaging and characterization platform will provide a significant increase in productivity for ...
(Date:7/19/2019)... ... July 19, 2019 , ... Improved Pharma LLC ... – Insights from Synchrotron X-ray Pair Distribution (SXPDF) Studies”. The authors are Stephen ... of Argonne National Laboratory and Gabriel de Araujo of the University of Sao ...
Breaking Biology News(10 mins):
(Date:6/26/2019)... VEGAS (PRWEB) , ... June 26, 2019 , ... Alice ... energy treatment on improving physicochemical properties of Magnesium Gluconate, which can prove to be ... Over 125% alteration of characteristic differentiation peak, change in crystallite size , ...
(Date:6/11/2019)... ... June 10, 2019 , ... Thought ... with the appointment of Biofeedback Tech Ltd as its authorised distributor ... essential part of many therapeutic treatments and clinical assessment protocols to treat stress ...
(Date:6/11/2019)... Calif. (PRWEB) , ... June 11, 2019 , ... ... company of Personalized Stem Cells Inc. (PSC) , has announced that their ... Public Health, Food and Drug Branch for manufacturing. This is an important ...
(Date:5/31/2019)... , ... May 29, 2019 ... ... patent applications from the USPTO providing proprietary interest to our methodology, processes, ... SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights including our proprietary ...
Breaking Biology Technology:
Cached News: